Keyphrases
Sulfonylurea
100%
Metformin
100%
Acarbose
100%
Retrospective Cohort Study
100%
Combination Therapy
100%
Glycemic Outcomes
100%
Fasting Plasma Glucose
40%
Hemoglobin A1c (HbA1c)
40%
Postprandial Glucose
40%
Type 2 Diabetes Mellitus (T2DM)
20%
Indonesia
10%
Jakarta
10%
No Significant Difference
10%
Cost-effectiveness
10%
Type 2 Diabetic Patients
10%
Treatment Efficacy
10%
Clinical Setting
10%
Army
10%
Regular Exercise
10%
Cohort Design
10%
Glycemic Parameters
10%
Pharmacological Therapy
10%
Cost Consideration
10%
Safety Considerations
10%
Medicine and Dentistry
Combination Therapy
100%
Sulfonylurea
100%
Glycon
100%
Retrospective Cohort Study
100%
Acarbose
100%
Glycemic
100%
Blood Glucose
70%
Hemoglobin A1c
40%
Maturity Onset Diabetes of the Young
20%
Drug Therapy
10%
Patient with Type 2 Diabetes
10%
Cost-Effectiveness Analysis
10%
Nursing and Health Professions
Metformin
100%
Sulfonylurea
100%
Cohort Analysis
100%
Combination Therapy
100%
Acarbose
100%
Glucose Blood Level
70%
Hemoglobin A1c
40%
Drug Therapy
10%
Diabetes Mellitus
10%
Non Insulin Dependent Diabetes Mellitus
10%
Public Hospital
10%
Patient with Type 2 Diabetes
10%
Cost Effectiveness Analysis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Sulfonylurea
100%
Metformin
100%
Cohort Study
100%
Acarbose
100%
Hemoglobin A1c
40%
Non Insulin Dependent Diabetes Mellitus
20%
Pharmacotherapy
10%